Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals
Residence in the most disadvantaged neighborhoods may be associated with lower amyloid pathology in cognitively impaired individuals.
Authors
- Margo B. Heston (ORCID: https://orcid.org/0000-0002-0980-2275)
- Justin Romanoff (ORCID: https://orcid.org/0000-0001-7058-9621)
- Nynikka R. Palmer (ORCID: https://orcid.org/0000-0002-5311-447X)
- B.V. Siegel (ORCID: https://orcid.org/0000-0001-6246-5792)
- Jon A. Steingrimsson (ORCID: https://orcid.org/0000-0003-2116-9377)
- Lucy S. Hanna
- C. Gatsonis
- Ganna Blazhenets (ORCID: https://orcid.org/0000-0003-2419-7373)
- Marı́a C. Carrillo
- Elena Tsoy
- Peggye Dilworth‐Anderson
- Charles Windon
- Torsten B. Neilands
- Consuelo H. Wilkins
- Jennifer Livaudais‐Toman
- Rachel A. Whitmer
- Bruce E. Hillner
- Bruce L. Miller
- Julene K. Johnson
- Katherine L. Possin
- Renaud La Joie
- Karen Smith
- Gil D. Rabinovici
Institutions
- University of North Carolina at Chapel Hill (US)
- Alzheimer's Association (US)
- San Francisco General Hospital (US)
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- Virginia Commonwealth University (US)
- Brown University (US)
- Mallinckrodt (United States) (US)
- University Memory and Aging Center (US)
- Institute on Aging (US)
- Global Brain Health Institute (US)
- University of California, Davis (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia Behavior & Socioeconomics of Aging
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/bsa3.70058
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- American College of Radiology Imaging Network
- Lantheus Medical Imaging
- Progenics Pharmaceuticals
- ECOG-ACRIN Cancer Research Group
- Novo Nordisk
- Siemens Healthineers
- National Institutes of Health
- Genentech
- Avid Radiopharmaceuticals